Koninklijke Philips (NYSE:PHG) Upgraded to “Hold” at Zacks Research

Koninklijke Philips (NYSE:PHG) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Thursday,Zacks.com reports.

A number of other research analysts also recently issued reports on PHG. Wall Street Zen downgraded shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research report on Saturday. Sanford C. Bernstein upgraded shares of Koninklijke Philips to a “hold” rating in a research note on Wednesday, December 17th. Royal Bank Of Canada began coverage on Koninklijke Philips in a research report on Wednesday, December 17th. They set a “sector perform” rating on the stock. Finally, Weiss Ratings raised Koninklijke Philips from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold”.

Koninklijke Philips Trading Down 0.5%

PHG opened at $31.25 on Thursday. The company has a current ratio of 1.32, a quick ratio of 0.86 and a debt-to-equity ratio of 0.63. The firm has a market cap of $30.09 billion, a price-to-earnings ratio of 29.48, a PEG ratio of 7.27 and a beta of 0.79. Koninklijke Philips has a 12 month low of $21.48 and a 12 month high of $33.44. The stock has a fifty day moving average price of $28.53 and a 200-day moving average price of $28.00.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings data on Tuesday, February 10th. The technology company reported $0.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.20. The company had revenue of $5.98 billion for the quarter, compared to the consensus estimate of $5.03 billion. Koninklijke Philips had a return on equity of 13.68% and a net margin of 5.09%. As a group, equities research analysts anticipate that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of PHG. Lido Advisors LLC raised its position in Koninklijke Philips by 3.7% during the fourth quarter. Lido Advisors LLC now owns 9,062 shares of the technology company’s stock valued at $247,000 after acquiring an additional 323 shares in the last quarter. Rhumbline Advisers grew its stake in shares of Koninklijke Philips by 1.3% during the 2nd quarter. Rhumbline Advisers now owns 29,306 shares of the technology company’s stock worth $703,000 after purchasing an additional 388 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Koninklijke Philips by 5.4% during the 4th quarter. EverSource Wealth Advisors LLC now owns 7,759 shares of the technology company’s stock valued at $210,000 after purchasing an additional 399 shares in the last quarter. Franklin Resources Inc. lifted its stake in shares of Koninklijke Philips by 3.9% in the 3rd quarter. Franklin Resources Inc. now owns 11,592 shares of the technology company’s stock valued at $316,000 after purchasing an additional 439 shares during the period. Finally, Kitching Partners LLC boosted its holdings in Koninklijke Philips by 4.2% during the second quarter. Kitching Partners LLC now owns 11,259 shares of the technology company’s stock worth $270,000 after buying an additional 457 shares in the last quarter. 13.67% of the stock is owned by institutional investors and hedge funds.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. (NYSE: PHG), commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips’ principal activities center on medical technologies and personal health.